SARTORIUS AG-VORZUG (SRT3.DE) Fundamental Analysis & Valuation

FRA:SRT3 • DE0007165631

Current stock price

209.3 EUR
-4.55 (-2.13%)
Last:

This SRT3.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SRT3.DE Profitability Analysis

1.1 Basic Checks

  • SRT3 had positive earnings in the past year.
  • SRT3 had a positive operating cash flow in the past year.
  • SRT3 had positive earnings in each of the past 5 years.
  • Each year in the past 5 years SRT3 had a positive operating cash flow.
SRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFSRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of SRT3 (1.65%) is worse than 68.75% of its industry peers.
  • The Return On Equity of SRT3 (5.97%) is worse than 68.75% of its industry peers.
  • With a Return On Invested Capital value of 5.11%, SRT3 is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
  • SRT3 had an Average Return On Invested Capital over the past 3 years of 4.49%. This is below the industry average of 7.18%.
  • The 3 year average ROIC (4.49%) for SRT3 is below the current ROIC(5.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.65%
ROE 5.97%
ROIC 5.11%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
SRT3.DE Yearly ROA, ROE, ROICSRT3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SRT3's Profit Margin of 4.58% is on the low side compared to the rest of the industry. SRT3 is outperformed by 62.50% of its industry peers.
  • In the last couple of years the Profit Margin of SRT3 has declined.
  • Looking at the Operating Margin, with a value of 15.73%, SRT3 is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • SRT3's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 45.59%, SRT3 is doing good in the industry, outperforming 68.75% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SRT3 has declined.
Industry RankSector Rank
OM 15.73%
PM (TTM) 4.58%
GM 45.59%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
SRT3.DE Yearly Profit, Operating, Gross MarginsSRT3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1

2. SRT3.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRT3 is destroying value.
  • SRT3 has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SRT3 has more shares outstanding
  • The debt/assets ratio for SRT3 has been reduced compared to a year ago.
SRT3.DE Yearly Shares OutstandingSRT3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SRT3.DE Yearly Total Debt VS Total AssetsSRT3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.21 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SRT3 has a Altman-Z score (2.21) which is in line with its industry peers.
  • The Debt to FCF ratio of SRT3 is 9.70, which is on the high side as it means it would take SRT3, 9.70 years of fcf income to pay off all of its debts.
  • SRT3 has a worse Debt to FCF ratio (9.70) than 62.50% of its industry peers.
  • A Debt/Equity ratio of 1.22 is on the high side and indicates that SRT3 has dependencies on debt financing.
  • The Debt to Equity ratio of SRT3 (1.22) is worse than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.7
Altman-Z 2.21
ROIC/WACC0.6
WACC8.54%
SRT3.DE Yearly LT Debt VS Equity VS FCFSRT3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • SRT3 has a Current Ratio of 0.91. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.91, SRT3 is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.52 indicates that SRT3 may have some problems paying its short term obligations.
  • The Quick ratio of SRT3 (0.52) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.52
SRT3.DE Yearly Current Assets VS Current LiabilitesSRT3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

5

3. SRT3.DE Growth Analysis

3.1 Past

  • SRT3 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.02%.
  • SRT3 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.76% yearly.
  • The Revenue has been growing slightly by 3.20% in the past year.
  • The Revenue has been growing by 8.66% on average over the past years. This is quite good.
EPS 1Y (TTM)-11.02%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%-80.37%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%1.9%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.14% on average over the next years. This is quite good.
  • Based on estimates for the next years, SRT3 will show a quite strong growth in Revenue. The Revenue will grow by 9.11% on average per year.
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.14%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y9.11%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SRT3.DE Yearly Revenue VS EstimatesSRT3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
SRT3.DE Yearly EPS VS EstimatesSRT3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

1

4. SRT3.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 55.08, which means the current valuation is very expensive for SRT3.
  • Based on the Price/Earnings ratio, SRT3 is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
  • The average S&P500 Price/Earnings ratio is at 26.54. SRT3 is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 31.21, the valuation of SRT3 can be described as expensive.
  • 75.00% of the companies in the same industry are cheaper than SRT3, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, SRT3 is valued a bit more expensive.
Industry RankSector Rank
PE 55.08
Fwd PE 31.21
SRT3.DE Price Earnings VS Forward Price EarningsSRT3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SRT3 is valued a bit more expensive than the industry average as 68.75% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as SRT3.
Industry RankSector Rank
P/FCF 35.36
EV/EBITDA 20.04
SRT3.DE Per share dataSRT3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRT3 does not grow enough to justify the current Price/Earnings ratio.
  • SRT3's earnings are expected to grow with 18.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.87
PEG (5Y)31.24
EPS Next 2Y18.45%
EPS Next 3Y18.59%

3

5. SRT3.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.44%, SRT3 is not a good candidate for dividend investing.
  • SRT3's Dividend Yield is a higher than the industry average which is at 0.57.
  • With a Dividend Yield of 0.44, SRT3 pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.44%

5.2 History

  • The dividend of SRT3 is nicely growing with an annual growth rate of 15.65%!
Dividend Growth(5Y)15.65%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • SRT3 pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of SRT3 is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP62.38%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
SRT3.DE Yearly Income VS Free CF VS DividendSRT3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SRT3.DE Dividend Payout.SRT3.DE Dividend Payout, showing the Payout Ratio.SRT3.DE Dividend Payout.PayoutRetained Earnings

SRT3.DE Fundamentals: All Metrics, Ratios and Statistics

SARTORIUS AG-VORZUG

FRA:SRT3 (4/29/2026, 5:30:03 PM)

209.3

-4.55 (-2.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength11.49
Industry Growth92
Earnings (Last)04-23
Earnings (Next)07-23
Inst Owners1.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.67B
Revenue(TTM)3.55B
Net Income(TTM)162.70M
Analysts80
Price Target378.25 (80.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.44%
Yearly Dividend0.73
Dividend Growth(5Y)15.65%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-37.31%
Min EPS beat(2)-82.17%
Max EPS beat(2)7.55%
EPS beat(4)2
Avg EPS beat(4)-20.08%
Min EPS beat(4)-82.17%
Max EPS beat(4)7.55%
EPS beat(8)3
Avg EPS beat(8)-10.51%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-0.97%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-0.97%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)0.69%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.48%
PT rev (3m)-2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.19%
EPS NY rev (3m)-5.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-1.83%
Valuation
Industry RankSector Rank
PE 55.08
Fwd PE 31.21
P/S 4.41
P/FCF 35.36
P/OCF 17.67
P/B 5.75
P/tB N/A
EV/EBITDA 20.04
EPS(TTM)3.8
EY1.82%
EPS(NY)6.71
Fwd EY3.2%
FCF(TTM)5.92
FCFY2.83%
OCF(TTM)11.84
OCFY5.66%
SpS47.47
BVpS36.41
TBVpS-34.21
PEG (NY)2.87
PEG (5Y)31.24
Graham Number55.797 (-73.34%)
Profitability
Industry RankSector Rank
ROA 1.65%
ROE 5.97%
ROCE 7.2%
ROIC 5.11%
ROICexc 5.54%
ROICexgc 21.21%
OM 15.73%
PM (TTM) 4.58%
GM 45.59%
FCFM 12.47%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
ROICexc(3y)4.83%
ROICexc(5y)9.64%
ROICexgc(3y)16.7%
ROICexgc(5y)28.15%
ROCE(3y)6.33%
ROCE(5y)12.7%
ROICexgc growth 3Y-19.62%
ROICexgc growth 5Y-7.23%
ROICexc growth 3Y-29.84%
ROICexc growth 5Y-12.08%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.7
Debt/EBITDA 3.4
Cap/Depr 104.8%
Cap/Sales 12.48%
Interest Coverage 3.05
Cash Conversion 90.28%
Profit Quality 272.4%
Current Ratio 0.91
Quick Ratio 0.52
Altman-Z 2.21
F-Score7
WACC8.54%
ROIC/WACC0.6
Cap/Depr(3y)122.42%
Cap/Depr(5y)145.08%
Cap/Sales(3y)13.7%
Cap/Sales(5y)13.08%
Profit Quality(3y)357.39%
Profit Quality(5y)249.46%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.02%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%-80.37%
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.14%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%1.9%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y9.11%
EBIT growth 1Y37.28%
EBIT growth 3Y-20.66%
EBIT growth 5Y2.17%
EBIT Next Year81.03%
EBIT Next 3Y32.63%
EBIT Next 5Y24.44%
FCF growth 1Y205.87%
FCF growth 3Y23.14%
FCF growth 5Y7.81%
OCF growth 1Y27.16%
OCF growth 3Y4.46%
OCF growth 5Y10.35%

SARTORIUS AG-VORZUG / SRT3.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.


Can you provide the valuation status for SARTORIUS AG-VORZUG?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.


What is the profitability of SRT3 stock?

SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for SRT3 stock?

The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 19.16% in the next year.


Can you provide the dividend sustainability for SRT3 stock?

The dividend rating of SARTORIUS AG-VORZUG (SRT3.DE) is 3 / 10 and the dividend payout ratio is 62.38%.